John Lydon
Progesterone receptors - animal models and cell signaling in breast cancer: Implications for breast cancer of inclusion of progestins in hormone replacement therapies
Progestins are included in menopausal hormone replacement therapy to counteract the increased risk for endometrial cancer associated with estrogen replacement therapy. Studies of hormone replacement therapy an...